Filing Details
- Accession Number:
- 0001209191-19-041963
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-12 17:17:06
- Reporting Period:
- 2019-04-05
- Accepted Time:
- 2019-07-12 17:17:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-05 | 183 | $6.29 | 4,183 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-09 | 50 | $6.31 | 4,233 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-12 | 50 | $6.28 | 4,283 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-16 | 34 | $6.14 | 4,317 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-17 | 19 | $6.07 | 4,336 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-24 | 22 | $5.96 | 4,358 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-26 | 26 | $5.92 | 4,384 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-30 | 18 | $5.79 | 4,402 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-02 | 48 | $5.38 | 4,450 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-07 | 43 | $6.15 | 4,493 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-10 | 76 | $5.91 | 4,569 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-15 | 51 | $5.66 | 4,620 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-17 | 44 | $6.19 | 4,664 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-21 | 50 | $6.61 | 4,714 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-24 | 75 | $6.48 | 4,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-29 | 50 | $6.43 | 4,839 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-31 | 50 | $6.47 | 4,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-04 | 50 | $6.49 | 4,939 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-07 | 65 | $6.28 | 5,004 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-11 | 50 | $6.23 | 5,054 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-13 | 50 | $6.32 | 5,104 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-17 | 50 | $6.23 | 5,154 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-19 | 50 | $6.25 | 5,204 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-21 | 50 | $6.24 | 5,254 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-25 | 50 | $6.46 | 5,304 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 50 | $6.38 | 5,354 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 50 | $6.42 | 5,404 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-03 | 50 | $6.36 | 5,454 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-08 | 50 | $6.27 | 5,504 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 50 | $5.97 | 5,554 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.